Oxygen-insensitive enzymatic reduction of oximes to imines.

The reduction of oximes to imines under anaerobic and aerobic conditions was studied using (E)- and (Z)-2,4,6-trimethylacetophenone oxime, benzaldoxime and (E)-2,4,6-trimethylbenzaldoxime. Pig and human liver microsomes, pig liver mitochondria and cytosol to a minor extent catalyzed the conversion of both isomeric ketoximes to the corresponding stable imine, the (E)-isomer being the better substrate. All reactions were oxygen-insensitive and required active protein and NADH or NADPH; however, NADH was preferred as cofactor. The reconstituted liver microsomal system of a pig liver CYP2D enzyme (NADH-benzamidoxime reductase), which is known to reduce N-hydroxylated derivatives of strongly basic functional groups, such as amidoximes, is also capable of reducing oximes. As expected, the corresponding imine was detected in relevant amounts when incubating 2,4,6-trimethyl-acetophenone oxime using the reconstituted enzyme system, but reduction rates were significantly lower compared to rates obtained when incubating benzamidoxime. Steric hindrance due to the methyl groups in ortho position to the oxime functionality could be excluded as being responsible for the lower conversion rates according to results obtained in incubations of 2,4,6-trimethylbenzamidoxime. When incubating benzaldoxime, only benzoic acid could be detected as metabolite, since the aldehyde is easily oxidized during incubation procedures, whereas incubations of (E)-2,4,6-trimethylbenzaldoxime also showed the formation of the corresponding aldehyde. These results allow us to postulate that the metabolism of aldoximes like 2,4,6-trimethylbenzaldoxime most likely proceeds through enzymatic reduction of the oxime to yield the intermediate imine, which is subsequently hydrolyzed to the aldehyde and then oxidized to the corresponding benzoic acid.

[1]  F. Kadlubar,et al.  Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. , 1974, Archives of biochemistry and biophysics.

[2]  H. Hucker,et al.  Phenylacetone oxime--an intermediate in the oxidative deamination of amphetamine. , 1971, Biochemical pharmacology.

[3]  B. Hollis,et al.  CYP3A4 is a Human Microsomal Vitamin D 25‐Hydroxylase , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Y. Hofmann,et al.  CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME , 2005, Drug Metabolism and Disposition.

[5]  J. Gorrod,et al.  Metabolic N-hydroxylation of substituted acetophenone imines. I. Evidence for formation of isomeric oximes. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[6]  B. Clement,et al.  Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes. , 2005, Life sciences.

[7]  S. Spielberg,et al.  N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[8]  D W Nebert,et al.  Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species. , 1978, The Journal of biological chemistry.

[9]  B. Testa Biochemistry of redox reactions , 1995 .

[10]  J. Groves,et al.  Models of Nitric Oxide Synthase: Iron(III) Porphyrin-Catalyzed Oxidation of Fluorenone Oxime to Nitric Oxide and Fluorenone , 1999 .

[11]  B. Clement REDUCTION OF N-HYDROXYLATED COMPOUNDS: AMIDOXIMES (N-HYDROXYAMIDINES) AS PRO-DRUGS OF AMIDINES , 2002, Drug metabolism reviews.

[12]  D. S. Beattie Enzyme localization in the inner and outer membranes of rat liver mitochondria. , 1968, Biochemical and biophysical research communications.

[13]  Jeffrey B. Cheng,et al.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Bodin,et al.  Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1. , 2003, Biochimica et biophysica acta.

[15]  C. Hauser,et al.  Formation of Certain Mesityl Ketoximes from Ketimines. Beckmann Rearrangements1 , 1955 .

[16]  B. Clement,et al.  HEPATIC, EXTRAHEPATIC, MICROSOMAL, AND MITOCHONDRIAL ACTIVATION OF THE N-HYDROXYLATED PRODRUGS BENZAMIDOXIME, GUANOXABENZ, AND RO 48-3656 ([[1-[(2S)-2-[[4-[(HYDROXYAMINO)IMINOMETHYL]BENZOYL]AMINO]-1-OXOPROPYL]-4-PIPERIDINYL]OXY]-ACETIC ACID) , 2005, Drug Metabolism and Disposition.

[17]  J. Cashman,et al.  Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. , 1997, Chemical research in toxicology.

[18]  R. Mcmahon,et al.  The mechanism of the oxidation of d-amphetamine by rabbit liver oxygenase. Oxygen-18 studies. , 1971, Biochemical and biophysical research communications.

[19]  D. Stiff,et al.  Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  S. Ohmori,et al.  Rat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[21]  J. Schenkman,et al.  The many roles of cytochrome b5. , 2003, Pharmacology & therapeutics.

[22]  D. Hainzl,et al.  Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz/b, ƒ /azepine-5-carboxamide, a potent anti-epileptic drug , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  L. Trepanier,et al.  NADH Cytochrome b5 Reductase and Cytochrome b5 Catalyze the Microsomal Reduction of Xenobiotic Hydroxylamines and Amidoximes in Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.

[24]  R. Mcmahon,et al.  The enzymatic N-hydroxylation of an imine. A new cytochrome P-450-dependent reaction catalyzed by hepatic microsomal monooxygenases. , 1971, The Journal of biological chemistry.

[25]  B. Clement,et al.  Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz. , 1996, Chemical Research in Toxicology.

[26]  B. Clement,et al.  Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[27]  K. Mihara Structure and regulation of rat liver microsomal stearoyl-CoA desaturase gene. , 1990, Journal of biochemistry.

[28]  K. Mihara,et al.  [9] Detergent-solubilized NADH-cytochrome b5 reductase , 1978 .

[29]  J. Boucher,et al.  Dehydration of alkyl- and arylaldoximes as a new cytochrome P450-catalyzed reaction: mechanism and stereochemical characteristics. , 1994, Biochemistry.

[30]  F. Tiemann Ueber die Einwirkung von Hydroxylamin auf Nitrile , 1884 .

[31]  Y. Yasukochi,et al.  Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. , 1976, The Journal of biological chemistry.

[32]  Kou-Chang Liu,et al.  A particularly convenient preparation of benzohydroximinoyl chlorides (nitrile oxide precursors) , 1980 .

[33]  M. Schultze-Mosgau,et al.  Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide. , 1993, Biochemical pharmacology.

[34]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[35]  L. K.‐C.,et al.  ベンゾヒドロキシイミノイルクロリド(ニトリルオキシド前駆体)の非常に便利な製造 , 1980 .

[36]  J. Ley,et al.  Hydroxy- or methoxy-substituted benzaldoximes and benzaldehyde-O-alkyloximes as tyrosinase inhibitors. , 2001, Bioorganic & medicinal chemistry.

[37]  A. Gangloff,et al.  Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst , 2001 .

[38]  C. Y. Huang Determination of binding stoichiometry by the continuous variation method: the Job plot. , 1982, Methods in enzymology.

[39]  K. S. Rogers,et al.  Localization of L-lactate dehydrogenase in mitochondria. , 1986, Archives of biochemistry and biophysics.

[40]  J. Cashman,et al.  N-oxygenation of primary amines and hydroxylamines and retroreduction of hydroxylamines by adult human liver microsomes and adult human flavin-containing monooxygenase 3. , 1996, Chemical research in toxicology.

[41]  J. Hauptmann,et al.  Reduction of a benzamidoxime derivative to the corresponding benzamidine in vivo and in vitro. , 1988, Die Pharmazie.

[42]  R. Estabrook,et al.  The measurement of difference spectra: application to the cytochromes of microsomes. , 1978, Methods in enzymology.

[43]  B. Clement,et al.  Isolation and Characterization of the Protein Components of the Liver Microsomal O2-insensitive NADH-Benzamidoxime Reductase* , 1997, The Journal of Biological Chemistry.

[44]  L. Trepanier,et al.  NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[45]  S. Kamachi,et al.  Metabolic activation of 1 α-hydroxyvitamin D 3 in human liver microsomes , 2001 .

[46]  S. Ohmori,et al.  Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide. , 1993, Molecular pharmacology.

[47]  L. Trepanier,et al.  UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE , 2005, Drug Metabolism and Disposition.

[48]  S. Ohmori,et al.  Formation of 2-sulphamoylacetylphenol from zonisamide under aerobic conditions in rat liver microsomes. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[49]  M. Ishigai,et al.  Oxime-metabolizing activity of liver aldehyde oxidase. , 1987, Archives of biochemistry and biophysics.

[50]  E. Ball,et al.  A Hemochromogen Component of Liver Microsomes. , 1952, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Kruger Ueber Abkömmlinge des Benzenylamidoxims , 1885 .

[52]  J. Boucher,et al.  N-hydroxyguanidines as new heme ligands: UV-visible, EPR, and resonance Raman studies of the interaction of various compounds bearing a C=NOH function with microperoxidase-8. , 2001, Biochemistry.

[53]  M. Zimmermann,et al.  Enzymatic Reduction of Benzamidoxime to Benzamidoxine , 1988, Archiv der Pharmazie.

[54]  P. L. Pickard,et al.  An Improved Method of Ketimine Synthesis , 1961 .

[55]  A. Cederbaum,et al.  Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction. , 1996, Archives of biochemistry and biophysics.

[56]  B. Judkins,et al.  A versatile synthesis of amidines from nitriles via amidoximes , 1996 .